Symposium:
121. Managing Hepatitis C
Friday, October 9, 2015: 10:30 AM-12:00 PM
Room: 6--DE

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe new treatment options for hepatitis C and their use with patients
  • summarize the latest treatment recommendations for patients with hepatitis C
  • discuss how to diagnose and manage advanced liver disease

Target Audience: Public health practitioners, Infectious diseases physicians, Members-in-training, Infectious diseases pediatricians, HIV specialists, HIV clinicians, Clinicians, Academicians

Tracks: Trainee, HIV-STD-TB, Adult ID

Moderators:  Pablo Tebas, MD, FIDSA, University of Pennsylvania and Michael T. Melia, MD, Johns Hopkins University School of Medicine

Presentations:
10:30 AM
713
New Drugs and How to Use them in Practice
Susanna Naggie, MD, MHS

11:00 AM
714
Hepatitis C Treatment: When to Start and Who to Treat
Mark Sulkowski, MD

11:30 AM
715
Diagnosing and Managing Advanced Liver Disease
Nancy Reau, MD, FAASLD, AGAF

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-174-L01-P

Disclosures:

P. Tebas, Merck: Consultant , Consulting fee
Glaxo: Consultant , Consulting fee

M. T. Melia, industry: Grant Investigator , Research support

See more of: Symposium
<< Previous Session | Next Session >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.